References
- Allen G. D. MODFIT: a pharmacokinetic computer program. Biopharmaceutical and Drug Disposition 1990; 11: 477–498
- Boyle G. W., Mc Killop D., Phillips P. J., Harding J. R., Pickford R., Mc Cormick A. D. The metabolism of Casodex in laboratory animals. Xenobiotica 1993; 23: 781–798
- Cockshott I. D., Cooper K. J., Sweetmore D. S., Blacklock N. J., Denis L. The pharmacokinetics of Casodex in prostate cancer patients after single and during multiple dosing. European Urology 1990; 18: 10–17, Suppl. 3
- Freeman S. N., Mainwaring W. I. P., Furr B. J. A. A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen, Casodex (ICI 176,334). British Journal of Cancer 1989; 60: 664–668
- Furr B. J. A. Casodex (ICI 176,334)—a new, pure, peripherally-selective antiandrogen: preclinical studies. Hormone Research 1989; 32: 69–76, Suppl. 1
- Furr B. J. A., Valcaccia B., Curry B., Woodburn J. R., Chesterson G., Tucker H. ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen. Journal of Endocrinology 1987; 113: 7–9
- Katchen B., Buxbaum S. Disposition of a new, nonsteroid, antiandrogen, α,α,α-trifluoro-2-methyl-4′-nitro-m-propiono-toluidine (Flutamide), in men following a single oral 200mg dose. Journal of Clinical and Endocrinological Metabolism 1975; 41: 373–379
- Katchen B., Dancik S., Millington G. Percutaneous penetration and metabolism of topical [14C]Flutamide in men. Journal of Investigative Dermatology 1976; 66: 379–382
- Newling D. W. W. The response of advanced prostatic cancer to a new non-steroidal antiandrogen: results of a multicenter open phase II study of Casodex. European Urology 1990; 18: 18–21, Suppl. 3
- Schulz M., Schmoldt A., Donn F., Becker H. The pharmacokinetics of Flutamide and its major metabolites after a single oral dose and during chronic treatment. European Journal of Clinical Pharmacology 1988; 34: 633–636
- Tucker H., Crook J. W., Chesterson G. J. Nonsteroidal anti-androgens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides. Journal of Medicinal Chemistry 1988; 31: 954–959